- Home
- NDRA vs SHPH Comparison
NDRA vs SHPH Comparison
Compare NDRA & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- SHPH
- Stock Information
- Founded
- NDRA 2007
- SHPH 2012
- Country
- NDRA United States
- SHPH United States
- Employees
- NDRA N/A
- SHPH N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- SHPH Health Care
- Exchange
- NDRA Nasdaq
- SHPH Nasdaq
- Market Cap
- NDRA 2.3M
- SHPH 2.3M
- IPO Year
- NDRA 2017
- SHPH 2022
- Fundamental
- Price
- NDRA $4.39
- SHPH $3.38
- Analyst Decision
- NDRA Strong Buy
- SHPH
- Analyst Count
- NDRA 1
- SHPH 0
- Target Price
- NDRA $46.00
- SHPH N/A
- AVG Volume (30 Days)
- NDRA 63.2K
- SHPH 35.9K
- Earning Date
- NDRA 08-14-2025
- SHPH 08-13-2025
- Dividend Yield
- NDRA N/A
- SHPH N/A
- EPS Growth
- NDRA N/A
- SHPH N/A
- EPS
- NDRA N/A
- SHPH N/A
- Revenue
- NDRA N/A
- SHPH N/A
- Revenue This Year
- NDRA N/A
- SHPH N/A
- Revenue Next Year
- NDRA N/A
- SHPH N/A
- P/E Ratio
- NDRA N/A
- SHPH N/A
- Revenue Growth
- NDRA N/A
- SHPH N/A
- 52 Week Low
- NDRA $2.90
- SHPH $3.00
- 52 Week High
- NDRA $25.90
- SHPH $82.50
- Technical
- Relative Strength Index (RSI)
- NDRA 40.24
- SHPH 42.94
- Support Level
- NDRA $4.42
- SHPH $3.09
- Resistance Level
- NDRA $4.92
- SHPH $3.49
- Average True Range (ATR)
- NDRA 0.36
- SHPH 0.21
- MACD
- NDRA -0.03
- SHPH 0.00
- Stochastic Oscillator
- NDRA 28.88
- SHPH 39.19
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.